y 27632 has been researched along with Disease Exacerbation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Achilefu, S; Alhallak, K; Azab, AK; Azab, F; de la Puente, P; DiPersio, JF; Duncan, K; Federico, C; Guenthner, N; Gurley, S; Hallahan, DE; Kapoor, V; King, J; Kohnen, D; Kotsybar, J; Markovic, M; Muz, B; Salama, NN; Sudlow, GP; Sun, J; Thotala, D; Vij, R; Wasden, K; Yuan, F; Zhang, L | 1 |
| Chen, R; Cheng, Y; Geng, L; Li, Z; Zhang, Y | 1 |
| Bidaud, A; Grise, F; Moreau, V | 1 |
| Brun, V; Esposito, B; Gojova, A; Groux, H; Loirand, G; Mallat, Z; Merval, R; Sauzeau, V; Silvestre, JS; Tedgui, A | 1 |
| Arii, S; Furumoto, K; Furuyama, H; Imamura, M; Isobe, N; Kaido, T; Mori, A; Murata, T; Nakamura, T; Nakao, T | 1 |
1 review(s) available for y 27632 and Disease Exacerbation
| Article | Year |
|---|---|
Rho GTPases in hepatocellular carcinoma.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Carcinoma, Hepatocellular; Disease Progression; Farnesyltranstransferase; Humans; Liver Neoplasms; Neoplasm Metastasis; Pyridines; rho GTP-Binding Proteins; Signal Transduction | 2009 |
4 other study(ies) available for y 27632 and Disease Exacerbation
| Article | Year |
|---|---|
Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma.
Topics: Amides; Animals; Apoptosis; Bortezomib; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Progression; Focal Adhesion Protein-Tyrosine Kinases; Human Umbilical Vein Endothelial Cells; Humans; Liposomes; Membrane Glycoproteins; Mice; Multiple Myeloma; Nanoparticles; P-Selectin; Protein Binding; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Signal Transduction; src-Family Kinases; Tumor Burden; Tumor Microenvironment | 2020 |
RhoC mediates invasion and migration of CaSki cells through the Rho-associated serine-threonine protein kinase 1 signaling pathway.
Topics: Amides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Female; Humans; Neoplasm Invasiveness; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; rhoC GTP-Binding Protein; Signal Transduction; Uterine Cervical Neoplasms | 2014 |
Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice.
Topics: Amides; Animals; Aorta; Arteriosclerosis; Cell Division; Cells, Cultured; Dietary Fats; Disease Progression; Enzyme Inhibitors; Food, Formulated; I-kappa B Proteins; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Protein Serine-Threonine Kinases; Pyridines; Receptors, LDL; rho-Associated Kinases; T-Lymphocytes; Transcription Factor RelA; Vasoconstriction | 2003 |
Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells.
Topics: Amides; Animals; Disease Progression; Enzyme Inhibitors; Homeodomain Proteins; Intracellular Signaling Peptides and Proteins; Liver; Liver Cirrhosis; Male; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; rho-Associated Kinases; RNA, Messenger | 2001 |